KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
has inked a collaboration with Divine Genes Sdn Bhd on the improvement and international distribution of genetic tests for reproductive health.
In a joint statement, the parties said Divine Genes’ genetic test for reproductive health will be added to Malaysian Genomics’ genetic test portfolio, which will market and distribute these tests in Malaysia and overseas.
Both parties will also cooperate in improving the product.
"This new, pioneering DNA-driven fertility test can help reproductive health specialists and their patients make important decisions in support of improving the outcome of fertility treatments.
"This test will form a critical part of Malaysian Genomics’ genetic screening portfolio of over 550 tests available across Southeast Asia and the Middle East where we have a presence," said Malaysian Genomics CEO Sasha Nordin.
Divine Genes director Dr Paul Suwinski added that the collaboration is a good platform for both parties to leverage on each other’s strengths in improving the product and expanding the market for the test.
